Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease that can affect most body systems. It is caused by a pathogenic variation in the TSC1 or TSC2 gene, 1,2 which is responsible for producing the proteins hamartin and tuberin respectively. The proteins form a complex involved in inhibiting the mammalian target of rapamycin pathway, which regulates cellular function, including proliferation, growth, and apoptosis. 3 In TSC, neurological characteristics, including seizures and structural brain changes, are common, occurring in around 90% of affected individuals. 4 Autism spectrum disorder (ASD) and intellectual disability are frequent outcomes occurring in around 50%. 5,6 ASD, which occurs in 1% to 4% of the general population, 7,8 is a lifelong neurodevelopmental disorder with social communication and restrictive and repetitive behaviour (RRB) impairments, with severity ranging from mild to profound. Most ASD is considered to be idiopathic, that is, there is no specific, identifiable, underlying cause; however, twin studies suggest that around 80% to 90% of ASD is due to complex, multifactorial